ERBB4 activation prevents microvascular dysfunction in a large animal model of hypertensive heart disease

2 September 2024 (14:30 - 14:40)

Organised by:

Video

Sign in for access options

Abstract

Slides

About the speaker

Doctor Tijs Bringmans

AZ Sint Maarten, Mechelen (Belgium)

5 More presentations in this session

Presentation thumbnail

Novel balloon catheter containing therapeutic mRNA with smart RNA switch alleviate restenosis after vascular injury

Doctor Y. Fu (Shanghai, CN)

Abstract Slides Video

Presentation thumbnail

Impact of neonatal hyperoxia on the development of the coronary vascular bed: an experimental model for the study of cardiomyopathy associated with premature birth

Doctor P. Girault-Sotias (Montreal, CA)

Abstract Slides Video

Presentation thumbnail

Parathyroid hormone exacerbates pulmonary hypertension via parathyroid hormone receptors on pulmonary artery smooth muscle cells

Assistant Professor Y. Joki (Tokyo, JP)

Abstract Slides Video

Presentation thumbnail

The novel role of complement 3 in Wnt5a-mediated vascular smooth muscle cell calcification

Doctor I. Badi (Oxford, GB)

Abstract Slides Video

Presentation thumbnail

Suppression of Fibulin 5 Attenuated Pulmonary Arterial Hypertension Associated with Congenital Heart Disease via Mitigating Pulmonary Arterial Smooth Muscle Cell Dysfunction

Doctor Y. Yang (Beijing, CN)

Abstract Slides Video

Access the full session

Session thumbnail

Novel insights into vascular remodelling

The Event

Event poster

ESC Congress 2024

2 September 2024 14:30 CET

You may be interested in

Congress Presentation

The development of small-molecule ERBB4 agonists as a treatment for heart failure

Congress Session

Young Investigator Award Session in Basic and Translational Sciences

Congress Session

Novel insights into vascular remodelling

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources